gptkbp:instance_of
|
gptkb:Company
gptkb:medical_devices
|
gptkbp:acquired_by
|
gptkb:Royal_Philips
|
gptkbp:acquisition
|
gptkb:Royal_Philips
|
gptkbp:ceo
|
gptkb:Scott_Huennekens
|
gptkbp:clinical_trial
|
ongoing
|
gptkbp:employees
|
approximately 300
|
gptkbp:founded
|
gptkb:1984
|
gptkbp:founder
|
gptkb:John_A._Mc_Donald
gptkb:John_A._Mc_Carthy
|
gptkbp:headquarters
|
gptkb:Colorado_Springs,_Colorado
|
https://www.w3.org/2000/01/rdf-schema#label
|
Spectranetics
|
gptkbp:industry
|
gptkb:medical_devices
|
gptkbp:investment_focus
|
cardiovascular diseases
|
gptkbp:market
|
global
|
gptkbp:partnerships
|
healthcare providers
|
gptkbp:products
|
laser atherectomy systems
coronary intervention devices
peripheral vascular intervention devices
|
gptkbp:regulatory_compliance
|
gptkb:FDA
|
gptkbp:research_and_development
|
gptkb:health_services
|
gptkbp:revenue
|
$100 million (approx.)
$100 million (2016)
|
gptkbp:services
|
vascular access procedures
|
gptkbp:specialization
|
cardiovascular interventions
|
gptkbp:specializes_in
|
vascular intervention
|
gptkbp:stock_symbol
|
SPNC
|
gptkbp:technology
|
gptkb:optics
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
gptkbp:website
|
www.spectranetics.com
|
gptkbp:bfsParent
|
gptkb:Philips
|
gptkbp:bfsLayer
|
4
|